𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Telomerase as a therapeutic target for malignant gliomas

✍ Scribed by Komata, Tadashi; Kanzawa, Takao; Kondo, Yasuko; Kondo, Seiji

Book ID
110066294
Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
245 KB
Volume
21
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Telomerase: a therapeutic target for the
Telomerase: a therapeutic target for the third millennium?
✍ FranΓ§ois Lavelle; Jean-FranΓ§ois Riou; Abdelazize Laoui; Patrick Mailliet πŸ“‚ Article πŸ“… 2000 πŸ› Elsevier Science 🌐 English βš– 231 KB

Telomerase offers the potential opportunity to control cell proliferation by interfering with a totally new and unique biological process which is cell senescence. The aim of this review is to impartially present the state of the art in telomerase with the pros and the cons of the current scientific

Mitochondria-bound hexokinase as target
Mitochondria-bound hexokinase as target for therapy of malignant gliomas
✍ StΓ©phane Oudard; Florence Poirson; Laurent Miccoli; Yveline Bourgeois; Anne Vass πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 806 KB

Hexokinase plays an important role in glucose-utilizing tissues like normal brain and cancers. In these tissues, hexokinase (HK) is mainly bound to mitochondria (mHK). Our objectives were to evaluate total HK (tHK) activity and mHK fraction in gliomas and to determine whether mHK binding could be ta

Molecularly targeted therapy for maligna
Molecularly targeted therapy for malignant glioma
✍ Sith Sathornsumetee; David A. Reardon; Annick Desjardins; Jennifer A. Quinn; Jam πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 473 KB πŸ‘ 1 views

## Abstract Malignant gliomas are relatively uncommon but lethal cancers. Despite recent research efforts in cancer therapy, the prognosis of patients with malignant gliomas has remained dismal. Understanding the molecular pathogenesis of glioma may lead to a rational development of new therapies.